A few studies in breast cancer and cervical adenocarcinoma have reported survival benefit for HLA-E expressing tumors [37, 38] while others, similar to us, reported a negative effect of HLA-E on OS in ovarian cancer, colorectal cancer and gastric cancer [27, 39–41]. This evidence concerns the gene HLA-E and ovarian cancer.